Natus Medical Incorporated (NTUS) Tops Q3 EPS by 8c, Revenues Beat; Offers FY20 EPS/Revenue Guidance Above Consensus

Go back to Natus Medical Incorporated (NTUS) Tops Q3 EPS by 8c, Revenues Beat; Offers FY20 EPS/Revenue Guidance Above Consensus
(NASDAQ: NTUS) Delayed: 32.96 --0 (-0%)
Previous Close $32.96    52 Week High
Open $0.03    52 Week Low
Day High $32.96    P/E N/A 
Day Low $32.96    EPS
Volume 31,396